

Publisher: Karger
E-ISSN: 1423-0267|235|1|42-48
ISSN: 0030-3755
Source: Ophthalmologica, Vol.235, Iss.1, 2016-0, pp. : 42-48
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Bimonthly Ranibizumab for Neovascular Age-Related Macular Degeneration
Ophthalmologica, Vol. 231, Iss. 2, 2013-12 ,pp. :





